Machine Learning

Dave Cantin Group's strategic hire of Nate Klebacha signals a new era of data-driven M&A as dealership consolidation continues to accelerate.

NEO Home Loans adopts Better's AI to slash mortgage decision times, signaling a new era of speed. But what are the risks behind the efficiency?

Rutgers Business School is overhauling its MBA in Professional Accounting, cutting costs and adding critical tech skills to prepare a new generation of CPAs.

Apple iSports hires innovation guru Ian Wilding to guide its Nasdaq ambitions, a move underscored by a corrective press release signaling growing pains.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

A brain aneurysm device successful in Europe has treated its first U.S. patient in a pivotal trial, promising to expand treatment options for thousands.

XPPen's new Artist Pro 27 (Gen 2) packs a 4K 120Hz screen, elite color accuracy, and a full suite of accessories to challenge the professional market.

OEM demand for certified, integrated security is reshaping the semiconductor market, driving M&A and a race to develop quantum-resistant technology.

A 30-year-old breakthrough could revolutionize physics and cancer detection. Its inventor now demands a public test to prove it, alleging a cover-up.

A new industry-led coalition is launching a national push to transform India's 7.69 crore MSMEs into global powerhouses. Can they succeed?

TMYTEK and Comtech launch new user terminals, including an ultra-efficient passive antenna, to deliver seamless satellite connectivity across all orbits.

New cardiology guidelines now include DNA risk scores, a move poised to revolutionize prevention and spot hidden threats before they strike.

With 1 million cars on the road, QCraft's CEO argues autonomous vehicles are not the end goal, but the training ground for a new era of physical AI.

Tescan's new Seoul demo lab is a strategic move to support South Korea's dominance in AI memory and advanced packaging amid a global chip war.

A new oral Alzheimer's drug shows potential for a lower, more patient-friendly dose, aiming to replace complex infusions with a simple daily pill.

Biotech firm Ribo Life Science reveals a new platform targeting the kidney, heart, and fat tissue, signaling a major shift for RNA-based medicines.

Arcfra's AECP 6.3 delivers a 4.6X performance leap and zero-data-loss resilience, positioning it as a potent, cost-effective rival to legacy cloud stacks.

Dematic's new Command Center platform uses AI to tackle data chaos, offering a single, vendor-agnostic view to boost efficiency and decision-making.

An influential guidelines update expands options for a tough-to-treat bladder cancer, giving patients access to a novel gene therapy beyond its FDA label.

A new AI-powered platform from TRACE ASI aims to give individual investors the market analysis tools once reserved for Wall Street's biggest players.